Patent · US Active

Treatment of acute ischemic stroke or intracranial bleeding with tPa and carbamylated erythropoietin

US8987190B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

H. LUNDBECK A/S · DK

Inventors

Thomas Nikolaj Sager · Aars, DK
Michael Chopp · Southfield, US
Zheng ZHANG · Wilmington, US

Key dates

Filing date	Nov 15, 2010
Grant date	Mar 24, 2015
Priority date	—
Expiry date	Oct 6, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates a method for the treatment of intracranial bleeding comprising administration of a therapeutically effective amount of tPa and a therapeutically effective amount of carbamylated erythropoietin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.